WEEKLY PACLITAXEL, CARBOPLATIN AND TRASTUZUMAB (WPCH) AS SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH HER2+METASTATIC BREAST CANCER: RESULTS OF A PHASE II STUDY

被引：0
|
作者：
Rozzi, Antonio [1 ]
Nardoni, Chiara [1 ]
Corona, Michela [1 ]
Restuccia, Maria Rosa [1 ]
Lanzetta, Gaetano [1 ]
机构：
[1] INI, Clin Oncol Unit, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: Results of a clinical phase II study
    Kohler, U
    Olbricht, SS
    Fuechsel, G
    Kettner, E
    Richter, B
    Ridwelski, K
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 40 - 43
  • [2] Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer
    Horita, Yosuke
    Nishino, Michiko
    Sugimoto, Saiho
    Kida, Akihiko
    Mizukami, Atsuyoshi
    Yano, Masaaki
    Arihara, Fumitaka
    Matsuda, Koichiro
    Matsuda, Mitsuru
    Sakai, Akito
    ANTI-CANCER DRUGS, 2019, 30 (01) : 98 - 104
  • [3] Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer
    Horita, Y.
    Nishino, M.
    Sugimoto, S.
    Kida, A.
    Mizukami, A.
    Yano, M.
    Arihara, F.
    Matsuda, K.
    Matsuda, M.
    Sakai, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+metastatic breast cancer
    Ruiz, M.
    Salvador, J.
    Bayo, J.
    Lomas, M.
    Moreno, A.
    Valero, M.
    Bernabe, R.
    Vicente, D.
    Jimenez, J.
    Lopez-Ladron, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 1085 - 1090
  • [5] Multicenter study of weekly trastuzumab, paclitaxel, and carboplatin followed by a week of rest every 28 days in patients with HER2+metastatic breast cancer
    Ruiz, M.
    Salvador, J.
    Bayo, J.
    Lomas, M.
    Moreno, A.
    Valero, M.
    Bernabe, R.
    Vicente, D.
    Jimenez, J.
    Lopez-Ladron, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Datko, F.
    D'Andrea, G.
    Dickler, M.
    Theodoulou, M.
    Goldfarb, S.
    Lake, D.
    Fornier, M.
    Modi, S.
    Sklarin, N.
    Comen, E.
    Fasano, J.
    Gajria, D.
    Drullinsky, P.
    Gilewski, T.
    Murphy, C.
    Syldor, A.
    Lau, A.
    Hamilton, N.
    Patil, S.
    Liu, J.
    Chandarlapaty, S.
    Hudis, C.
    Dang, C.
    CANCER RESEARCH, 2012, 72
  • [7] Multicenter study of weekly trastuzumab, paclitaxel and carboplatin followed by a week of rest every 28 days in patients with HER2+metastatic breast cancer (MBC)
    Ruiz, M.
    Salvador, J.
    Bayo, J.
    Lomas, M.
    Moreno, A.
    Valero, M.
    Bernabe, R.
    Vicente, D.
    Jimenez, J.
    Lopez-Ladron, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Weekly paclitaxel and trastuzumab as first-line chemotherapy in patients with her-2 positive metastatic breast cancer
    Kim, Jin-Soo
    Han, Hye-Suk
    Im, Seock-Ah
    Oh, Do-Youn
    Han, Won-Shik
    Lee, Se-Hoon
    Kim, Dong-Wan
    Kim, Tae-You
    Noh, Dong-Young
    Bang, Yung-Jue
    ANNALS OF ONCOLOGY, 2006, 17 : 85 - 85
  • [9] Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer
    Burris, H
    Yardley, D
    Jones, S
    Houston, G
    Broome, C
    Thompson, D
    Greco, FA
    White, M
    Hainsworth, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1621 - 1629
  • [10] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Datko, Farrah Mikhail
    D'Andrea, Gabriella
    Dickler, Maura N.
    Theodoulou, Maria
    Goldfarb, Shari Beth
    Lake, Diana
    Fornier, Monica Nancy
    Modi, Shanu
    Sklarin, Nancy T.
    Comen, Elizabeth Anne
    Fasano, Julie
    Gajria, Devika
    Drullinsky, Pamela
    Murphy, Conleth G.
    Syldor, Angemael
    Patil, Sujata
    Liu, Jennifer
    Chandarlapaty, Sarat
    Hudis, Clifford
    Dang, Chau T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
12345